000 03172nam a22003855i 4500
999 _c11617
_d11617
001 11617
003 DE-He213
005 20210720040355.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180828s2018 gw | s |||| 0|eng d
020 _a9783319911106
024 7 _a10.1007/978-3-319-91110-6
_2doi
040 _bspa
_dES-VaUE
050 4 _aRC685.5
_b.M96 2018 EB
245 1 0 _aT1-Mapping in Myocardial Disease :
_bPrinciples and Applications
_cedited by Phillip C. Yang.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _aX, 113 p. 47 illus., 41 illus. in color.
_bonline resource
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 _aMedicine (Springer-11650)
505 0 _aFundamentals of Cardiac T1 Mapping -- T1 Mapping in Cardiac Hypertrophy -- T1 mapping in cardiomyopathy from cancer treatment -- Comparison of T1 mapping by cardiac MRI to non-cardiac MRI methods to evaluate cardiac fibrosis -- T1 Mapping in Aortic Stenosis -- T1 Mapping in Peri-Infarct Injury in Ischemic Cardiomyopathy -- T1 mapping in stem cell therapy -- T1 Mapping in Uncommon Non-Ischemic Cardiomyopathies.
520 _aThis book details the advances in cardiac MRI that have enabled quantitative tissue characterization of the myocardium using myocardial and blood T1 measurements, which have enabled reliable detection of diffuse pathological processes in both the cardiomyocytes and the interstitial cells of the myocardium. Evaluation of the native myocardial and interstitial fibrosis, and measurement of the extracellular volume fraction has allowed an unprecedented opportunity to elucidate the pathology, diagnosis and prognosis of cardiovascular disease. T1-Mapping in Myocardial Disease: Principles and Applications reviews a wide spectrum of significant cardiovascular disease and provides relevant guidance for the clinical implementation of this innovative technique. The specific topics covered include principles of T1-mapping in cardiovascular disease and the role of T1-mapping in hypertensive heart disease and hypertrophic cardiomyopathy, cardiotoxicity from cancer treatment, cardiacfibrosis, left ventricular hypertrophy in aortic stenosis, peri-infarct injury in ischemic cardiomyopathy, and stem cell therapy. This comprehensive coverage of the utility of T1-mapping in cardiovascular diseases will greatly appeal to the entire cardiovascular medicine and imaging communities. .
653 0 _aCardiology.
653 0 _aRadiology, Medical.
700 1 _aYang, Phillip C.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
776 0 8 _iPrinted edition:
_z9783319911090
776 0 8 _iPrinted edition:
_z9783319911113
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-91110-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0